MedPath

FLUPHENAZINE DECANOATE INJECTION, USP

FLUPHENAZINE DECANOATE INJECTION, USP

Discontinued
DIN Number

02383225

Drug Class

Human

Market Date

N/A

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02383225
AIG Number0110769001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AB02 FLUPHENAZINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Subcutaneous
AHFS Classification28:16.08.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUPHENAZINE DECANOATEActive
Strength: 25 MG / ML
Monograph: FLUPHENAZINE DECANOATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.